Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cornerstone Funds File Their Annual Reports
-
Global Crossing Airlines Reports Fourth Quarter & Full Year 2025 Financial Results
-
Global Water Resources Reports Full Year 2025 Results
-
ATN Reports Fourth Quarter and Full Year 2025 Results; Provides 2026 Outlook
-
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
-
Monthly information on share capital and company voting rights
-
DBV Technologies to Participate in Upcoming March Investor Conferences
-
MISTRAS Announces Fourth Quarter and Full Year 2025 Results
-
Costamare Inc. Announces Availability of Its Annual Report on Form 20-F for the Year Ended December 31, 2025
-
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
-
NN, Inc. Reports Fourth Quarter and Full Year 2025 Results
-
Sachem Capital Corp. Announces Common and Preferred Dividends
-
Enviri Corporation Announces Early Termination of Hart-Scott-Rodino Act Waiting Period for Proposed Sale of Clean Earth to Veolia
-
Castellum, Inc. Announces 2025 Unaudited Financial Results
-
Cohen & Company Sets Release Date for Fourth Quarter & Full Year 2025 Financial Results
-
Natural Resource Partners L.P. 2025 Form 10-K Now Available
-
Clarus Announces $0.025 Per Share Quarterly Dividend
-
Cohen & Company Sets Release Date for Fourth Quarter & Full Year 2025 Financial Results
-
COMPX DECLARES REGULAR QUARTERLY DIVIDEND
-
COMPX REPORTS FOURTH QUARTER 2025 RESULTS
-
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
-
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance
-
Rigetti Computing Reports Fourth Quarter and Full-Year 2025 Financial Results
-
Hudson Technologies Reports Fourth Quarter and Year-End 2025 Results
-
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
-
LB Pharmaceuticals to Participate in Upcoming March Investor Events
-
Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2025 Results
-
Pulmonx Announces Closing of up to $60 Million Credit Facility
-
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
-
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
-
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
-
James River Recruits Industry Veteran Kelly Hadiaris to Lead Excess Casualty
-
Safe Bulkers Announces Filing of 2025 Annual Report on Form 20-F
-
NCS Multistage Holdings, Inc. Announces Fourth Quarter and Full Year 2025 Results
-
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
-
Pulmonx Announces Closing of up to $60 Million Credit Facility
-
Coherent Launches 224Gbps Quad TIA for Next-Generation AI and Cloud Infrastructure
-
red violet Announces Fourth Quarter and Full Year 2025 Financial Results
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
-
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
-
Motorsport Games to Report Fourth Quarter and Full Year 2025 Financial Results
-
Bowman Reports Results for Fourth Quarter and Full Year 2025; Raises 2026 Guidance
-
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Grocery Outlet Holding Corp. Announces Fourth Quarter and Fiscal 2025 Financial Results
-
Five Below, Inc. Announces Fourth Quarter and Full Year Fiscal 2025 Earnings Release and Conference Call Date
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Galapagos Receives Transparency Notifications from Bank of America

